(NASDAQ: CLPT) Clearpoint Neuro's forecast annual revenue growth rate of 39.2% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 12.11%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,551.19%.
Clearpoint Neuro's revenue in 2026 is $34,332,000.On average, 4 Wall Street analysts forecast CLPT's revenue for 2026 to be $1,609,043,466, with the lowest CLPT revenue forecast at $1,504,161,459, and the highest CLPT revenue forecast at $1,701,134,984. On average, 3 Wall Street analysts forecast CLPT's revenue for 2027 to be $2,139,592,933, with the lowest CLPT revenue forecast at $2,055,687,328, and the highest CLPT revenue forecast at $2,202,522,137.
In 2030, CLPT is forecast to generate $4,592,353,874 in revenue, with the lowest revenue forecast at $4,412,150,101 and the highest revenue forecast at $4,727,364,587.